晨光生物(300138.SZ):擬提前贖回“晨光轉債”
格隆匯 1 月 13日丨晨光生物(300138.SZ)公佈,公司第四屆董事會第二十七次會議決議,審議通過了《關於提前贖回“晨光轉債”的議案》;
公司於2020年6月17日公開發行可轉換公司債券(“可轉債”或“晨光轉債”)於2020年12月23日起進入轉股期,公司股票自2020年12月23日至2021年1月13日連續15個交易日的收盤價格均不低於當期轉股價格(12.25元/股)的130%(15.93 元/股),已觸發《晨光生物科技集團股份有限公司創業板公開發行可轉換公司債券募集説明書》中約定的有條件贖回條款:“在轉股期內,如果公司股票在任何連續三十個交易日中至少有十五個交易日的收盤價格不低於當期轉股價格的130%(含130%)”。
為優化公司資本結構、降低財務費用,董事會同意公司行使可轉債提前贖回權,按照可轉債面值加當期應計利息的價格贖回在贖回登記日收市後登記在冊的全部“晨光轉債”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.